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Abatract 
Introduction: Injectable contraception is the most widely used type of contraception by Indonesian 
mothers because of its effective way of working, practical use, and lower price. However, in the use of 
injectable contraception, there are side effects, one of which is weight gain. Objective: To find out the 
differences in weight gain for 1-month and 3-months of injecting contraceptive acceptors. Method: This 
was an analytical observational study with a cross-sectional design. This research was conducted at the 
Independent Practice Midwife of Sri Retnaningtyas, Tambaksari District, Surabaya. The total sample is 110 
respondents with a consecutive sampling technique. Data collection using medical records and statistical 
tests using independent sample t-test. Results: Analyzing the weight gain in the contraceptive injection 
acceptor that is the average injection of 1-month experienced of 2.16 kilograms and injections of 3-months 
experienced of 2.95 kilograms. The results of the independent t-test with a significance value of 0.039 (p 
<0.05). Conclusion: There was a significant difference in weight gain between 1-month and 3-months 
injective contraception acceptors, with the highest increase occurred in 3-months, injective contraceptive 
acceptors. 
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Introduction 
The high rate of population growth is now also a 
big problem in Indonesia. One of the strategic 
decisions taken by the Indonesian government to 
reduce the rate of population growth is the 
National Family Planning program which aims to 
ban pregnancy using contraceptive methods for 
pregnancy prevention and family planning12. There 
are currently many methods or contraceptives 
available including IUD, Injections, Pills, Implants, 
Contraception, Body condoms3. 
Based on 2014 BKKBN data in Indonesia the 
percentage of injectable contraception usage was 
52.62%, Pill 26.63%, Condom 5.50%, IUD 6.92%, 
Implant 6.96%, MOW 1.28%, and MOP 0.09%4. 
Injecting contraceptives is often chosen by 
mothers in Indonesia because of the effective way 
they work and how to use them, besides that the 
prices are also cheaper3. Report data on the 
achievement of new acceptors in East Java in 2014 
were Injections 58.87%, Pills 21.93%, Condoms 
3.10%, IUD 8.02%, Implants 6.38%, MOW 
1.64%, and MOP 0.06%4. This shows that if 
contraceptive injectors are much sought after by 
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acceptors. One side effect that is often complained 
of the use of injectable contraception is weight 
gain5. 
A study conducted by Susila & Oktaviani (2015) 
entitled "The Relationship of Injecting 
contraception with the Increase in Acceptor 
Weight (Study in BPS Dwenti KR, Sumberejo 
Village, Lamongan Regency)" showed that 26 out 
of 28 acceptors of injecting birth control (92.9%) 
experienced an increase in body weight body and a 
small portion did not experience weight gain of 2 
acceptors out of 28 injecting contraceptive 
acceptors (7.1%). This shows the relationship of 
injectable contraception with the acceptor's 
bodyweight. Other factors that can affect weight 
gain such as age, mental health, heredity, food, and 
the environment. 
To support further research and strengthen 
previous research researchers want to find out the 
extent to which the comparison of weight gain in 
1-month and 3-months injectable contraception 
acceptors, and whether 1-month and 3-months 
injectable contraceptive acceptors can cause weight 
gain so far can be justified or not, the researcher is 
very interested in finding the answer by scientific 
proofing through a research that directly uses data 
and then is compared and focused to find out the 
extent of weight gain comparison between 1-
month and 3-months injectable contraception 
acceptors within a certain period. 
Methods  
This type of research is observational analytic with 
cross-sectional design because this study observes 
weight gain simultaneously in individuals of a 
population at a time. The population in this study 
were all women who used 1-month and 3-months 
contraceptive injections in the January-September 
2019 period in the Independent Practice Midwife 
of Sri Retnaningtyas, Tambaksari District, 
Surabaya. The inclusion criteria included patients 
who used 1-month and who used 3-months 
injection birth control, patients who used routine 
birth control in the period (January-September 
2019), aged 20-35 years, did not use other types of 
birth control. The sampling technique in this study 
was consecutive sampling. 
The independent variables in this study were the 
category of contraceptive contraception (1-month 
and 3-months contraceptive injection) and the 
dependent variable is weight gain. Data analysis 
using univariate and bivariate analysis. The 
univariate analysis assesses the distribution or 
normality of data from each variable, both the 
independent variable and the dependent variable. 
This data analysis technique uses a simple statistical 
calculation that is presentation or proportion. 
Bivariate analysis, to test the average difference. In 
this study using the t-test that is an independent 
sample t-test. The number of samples is calculated 
using the cross-sectional formula, the results are: 
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𝑛
=







 𝑎: 1,64 at the level of trust 90% 
𝑍 𝛽: 0,84 at the level of strength 80% 
𝑃1 : Estimated outcome probability in the 
population 1 = 55,4% (Sri Retnaningtyas, 2019, not 
publish) 
𝑃2: Estimated outcome probability in the 
population 2 = 31,8% (Sri Retnaningtyas, 2019, not 
publish) 
?̅?: (𝑃1+ 𝑃2)/2 = 0,436;  𝑛: 53 
The number of samples needed for each group is a 
minimum of 53 
Result and Discussion  
The data in this study are secondary data from the 
medical record of the Independent Practice 
Midwife of Sri Retnaningtyas during the period 
January to September 2019. The number of 
samples used in this study was 110 respondents 
divided into 2 groups, namely 1-month and 3-
months injectable contraception every 55 
respondents. The characteristics of 1-month and 3-
months injectable contraceptive acceptors can be 
determined based on age and initial and final body 
weight. Descriptive the characteristics of 1-month 
and 3-months injectable contraceptive acceptors 
can be seen in the following table 1: 
Table 1 Characteristic 1-month and 3-months Injectable Contraceptive Acceptor 
Characteristic Means ± SD Minimum Maximum 
Injectable Contraception 1-month Acceptor 
Age (years) 31,1±3,29 22 35 
First BW (kg) 58,9±8,48 44,00 79,00 
Final BW (kg) 61,1±8,32 45,80 80,80 
Injectable Contraception 3-months Acceptor 
Age (years) 30,8±4,00 21 35 
First BW (kg) 57,4±8,96 40 75,60 
Final BW (kg) 60,4±9,17 43,70 79,00 
BW: bodyweight    
It describes that the average age of 1-month 
injectable contraceptive acceptors is 31,1±3,29 
years. Besides that, the youngest respondent has the 
age of 22 years and the oldest has the age of 35 
years. The initial body weight of 1-month injectable 
contraception acceptors has an average of 
58,9±8,48 kilograms. While the final bodyweight of 
1-month injectable contraceptive acceptors has an 
average of 61,1±8,32 kilograms. This shows that 
there is an increase in the average body weight of 1-
month injectable contraceptive acceptors in the 
period January to September 2019 at table 1 upside. 
At table 1 bottom side, It can be seen that the 
average age of 3-months injectable contraceptive 
acceptors is 30,8±4,00 years. The youngest 
respondent has 21 years old and the oldest was 35 
years old. The first bodyweight of 3-months 
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injectable contraceptive acceptors has an average of 
57,4±8,96 kilograms, and the final body weight of 
3-months injectable contraceptive acceptors has an 
average of 60,4±9,17 kilograms. This shows that 
there is an increase in the average body weight of 3-
months injectable contraceptive acceptors in that 
period.  According to table 1, it is known that both 
injectable contraceptives, 1-month, and 3-months 
have the same effect to increase bodyweight. 
The Weight Gain of 1-month and 3-months 
Injectable Contraceptive Acceptor 
Before conducting a bivariate analysis, a normality 
test for distribution is performed on each data to 
determine the appropriate analysis method. The 
normality test is carried out with the Shapiro Wilk 
test with the following results as listed in table 2: 
Table 2 Normality Test of Bodyweight of 1-month and 3-months Injectable Contraceptive Acceptor 
Bodyweight Shapiro Wilk p Distribution 
Injectable Contraception 1-month Acceptor 
First  0,963 0,086 Normal 
Final  0,974 0,270 Normal 
Injectable Contraception 3-months Acceptor 
First  0,982 0,590 Normal 
Final  0,978 0,397 Normal 
The result of the Shapiro Wilk test can be seen in 
table 2 that the significant value in both data for 1-
month injectable contraceptive acceptors is 0.086 
(p>0.05) for the first bodyweight and 0,270 
(p>0.05) for final bodyweight. This shows that 
both data regarding initial body weight and final 
bodyweight for injectable contraceptive acceptors 
for 1-month were normally distributed.  
At the below position of table 2, it is known that 
the significant value for 3-months injectable 
contraceptive acceptors in both data is 0,982 
(p>0.05) for first bodyweight and 0,978 (p>0.05) 
for final bodyweight. This shows that both the data 
regarding the first and final body weight of 
respondents with a 3-months injectable 
contraceptive acceptor were normally distributed. 
So that the bivariate analysis regarding weight gain 
for injectable contraceptive acceptor 1-month and 
3-months were analyzed by paired t-test.  
Based on table 3, it can be seen that the average first 
bodyweight of 1-month injectable contraceptive 
acceptors is 58,94±8,48 kilogram and final body 
weight of 61,10 ± 8,32 kilogram so that the average 
weight gain that occurs in 1-month injectable 
contraceptive acceptors is 2.16 kilogram The 
results of the analysis by paired t-test obtained a 
significance value of 0,000 (p<0.05). This shows a 
significant increase in first to final bodyweight for 
1-month injectable contraceptive acceptors. 
The result is on that table 3, also can be seen that 
the average first bodyweight of 3-months injectable 
Khoiriya Ardiani et al 
67                                        Magna Medica   Vol 7  |  No 2  August  2020 
contraceptive acceptors is 57,43±8,96 kilogram 
and final body weight of 60,38±9,17 kilogram so 
that the average weight gain that occurs in 3-
months injectable contraceptive acceptors is 2.95 
kilogram The results of the analysis by paired t-test 
obtained a significance value of 0,000 (p<0.05). 
This shows a significant increase in first to final 
bodyweight for 3-months injectable contraceptive 
acceptors. 
Table 3 A paired t-test of Bodyweight of 1-month and 3-months Injectable Contraceptive Acceptor  
Bodyweight Means ± SD t p 
Injectable Contraception 1-month Acceptor 
First  58,94 ± 8,48 
-7,940 0,000 
Final  61,10 ± 8,32 
Injectable Contraception 3-months Acceptor 
First  57,43 ± 8,96 
-11,261 0,000 
Final  60,38 ± 9,17 
Comparison of The Weight Gain of Injectable Contraceptive Acceptor 1-month to 3-months 
Table 4 Independent t-test of Weight Gain of 1-month to 3-months Acceptor 
Weight Gain Means ± SD t p 
1-month Acceptor 2,16 ± 2,02 
-2,090 0,039 
3-months Acceptor  2,95 ± 1,94 
At table 4 above, it points out that the average 
weight gain of a 1-month injectable contraceptive 
acceptor is 2.16 kilogram with a standard deviation 
of 2.02 kilogram. While the average weight gain of 
the 3-months injectable contraceptive acceptor was 
2.95 kilograms with a standard deviation of 1.94 
kilograms. So that the increase in injectable 
contraceptive acceptor bodyweight 3-months was 
higher than the increase in  1-month injectable 
contraceptive acceptor bodyweight. This was also 
shown by the results of the independent t-test with 
a significance value of 0.039 (p<0.05) which 
showed a significant difference in weight gain 
between 1-month and 3-months injectable 
contraceptive acceptors. 
This is consistent with the theory that is said by 
Saifuddin (2003)7 where the composition of each 
injectable contraception shows that the content of 
the hormone progesterone in 1-month injectable 
contraception is only 25 mg depo 
medroxyprogesterone acetate while the content of 
the hormone progestin in 3-months contraceptive 
injecting is 150 mg Depo Medroxyprogesterone 
Acetate8. 
Mansjoer in 2003 in Wahyuningsih and Putri 
(2015) also suggested that a factor influencing the 
change in body weight for injectable contraceptive 
acceptors was the presence of a strong 
progesterone hormone that stimulated the appetite 
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hormone in the hypothalamus. With the appetite 
more than usual, the body will excess nutrients. 
Excess nutrients by the hormone progesterone are 
converted to fat and stored under the skin. This 
change in body weight is due to the accumulation 
of excess fat resulting from synthesis from 
carbohydrates to fat8. 
The results of this study are in line with the results 
of a study conducted by Wahyuningsih (2015)8 
regarding a comparative study of weight gain at 1-
month and 3-months injectable contraceptive 
acceptors at the Griya Husada Karanganyar Clinic. 
In this study, it was found that the results of the 
analysis of the Mann Whitney test showed that the 
significance value was 0,000 (p<0,05), which 
indicates that Ho was rejected and Ha was 
accepted, which means there was a difference in 
weight gain for injectable contraceptive acceptors 
1-month and 3-months. Where this is in 
accordance with the theory that the use of both 
injectable contraceptive monthly and 3-months 
have major side effects, namely changes in body 
weight8. 
A study reported weight gain in 3-months 
injectable birth control acceptors of more than 2.3 
kilograms in the first year and subsequently 
increased gradually to reach 7.5 kilograms for six 
years. While the use of a 1-month injectable 
contraceptive, bodyweight increased by an average 
of 2 to 3 kilograms in the first year of use and 
continued to increase during the second year9. 
Weight gain also depends on hormonal conditions, 
age, psychology, psychological, heredity, food, and 
physical environment of each individual. In this 
study, researchers did not examine further about 
other factors of weight gain9. This is because in this 
study more focused on weight gain due to the side 
effects of hormonal birth control use, namely the 
injectable contraceptive of 1-month and 3-months. 
Conclusion  
The conclusions obtained in this study are as 
follows: first, there is a significant increase in initial 
bodyweight and final bodyweight for 1-month and 
3-months contraception acceptors; and the en 1-
month and 3-months injectable contraception 
acceptors, with the highest increase occurring at 3-
months injectable contraception acceptors. 
Acknowledgment 
Thank you to Midwife Sri Retnaningtyas, 
Tambaksari District Surabaya for providing the 
opportunity to conduct research in her private 
practice 
References  
1.  Lette AR. Sumber Informasi dan Peran 
Significant Others dalam Program Keluarga 
Berencana di Klinik Pratama Citra Husada 
Kupang. J Publ Kesehat Masy Indones. 
2018;5(1):35–9.  
2.  Anas M, Samsulhadi. Angka Kejadian 
Kehamilan Pada Penderita Infertil Dengan 
Endometriosis Minimal Ringan Yang 
Mendapatkan Terapi Medroksi Progesteron 
Asetat Oral Di RSUD Dr Sutomo Surabaya. 
Maj Obstet dan Ginekol [Internet]. 
Comparison of Weidht Gain in Injectable Contraceptive 1-Month And 3-Month Acceptors at The Independent Midwife Practice Tambaksari Surabaya 
 
                                                                                            69                                          Magna Medica   Vol 7  |  No 2  August  2020 







3.  Farida F. Use of Injecting Contraceptives 
and Pills Against Weight Gain in Mothers of 
Fertile Age Couples. Str J Ilm Kesehat. 
2017;6(2):43–7.  
4.  Septalia R, Puspitasari N. Factors That 
Influence the Choice of the Contraceptive 
Method. J Biometrika dan Kependud. 
2017;5(2):91–8.  
5.  Rachma A, Widatiningsih S. Difference in 
Weight Gain in 3-months and 1-month 
injection contraception acceptors in Karang 
Kidul, Magelang Selatan district, Magelang 
city. J Kebidanan. 2016;5(10):38–46.  
6.  Susila I, Oktaviani TR. The Relationship of 
Injecting Contraception with the Increase in 
Acceptor Body Weight (Study at BPS 
Dwenti K.R. Sumberejo Village, Lamongan 
Regency 2015). J Kebidanan. 2015;7(2):8.  
7.  PA HE. Panduan Praktis Pelayanan. Jakarta: 
Yayasan Bina Pustaka Sarwono 
Prawirohardjo; 2016. 133 p.  
8.  Wahyuningsih IR, Putri AK. Comparison 
Study On Weight Gain The Acceptors 
Injection 1 Month And 3 Months In Clinical 
Griya Husada Karanganyar. 
PLACENTUM. 2015;3(1).  
9.  Setyoningsih FY. Difference in Weight Gain 
in Combined Injection Contraception 
Acceptor and DMPA Injection at BPS Y. Sri 
Suryaningsih Kulon Progo. J Kesehat 
“Akbid Wira Buana.” 2018;3(2):1–9. 
 
